180 related articles for article (PubMed ID: 3551883)
21. [Clinical research on the hypolipidemic action of a probucol preparation].
Naumova R; Kerekovska M; Goranov I; Balabanski L
Vutr Boles; 1986; 25(2):73-7. PubMed ID: 3716382
[TBL] [Abstract][Full Text] [Related]
22. [Probucol treatment of hyperlipidemia].
Koizumi J
Nihon Rinsho; 1994 Dec; 52(12):3279-84. PubMed ID: 7853723
[TBL] [Abstract][Full Text] [Related]
23. Influence of probucol on cholesterol and lipoprotein metabolism in man.
Kesäniemi YA; Grundy SM
J Lipid Res; 1984 Aug; 25(8):780-90. PubMed ID: 6491523
[TBL] [Abstract][Full Text] [Related]
24. [Behavior of high-density lipoproteins in drug lipid-lowering treatment].
Mordasini R; Riesen W; Oster P; Riva G
Schweiz Med Wochenschr; 1982 Jan; 112(3):95-8. PubMed ID: 7058319
[TBL] [Abstract][Full Text] [Related]
25. Curcumin attenuates diet-induced hypercholesterolemia in rats.
Arafa HM
Med Sci Monit; 2005 Jul; 11(7):BR228-234. PubMed ID: 15990684
[TBL] [Abstract][Full Text] [Related]
26. [Lipoprotein cholesterol in the blood plasma of rats with a bile circulation disorder].
Finagin LK; Litovka IG
Fiziol Zh (1978); 1989; 35(4):103-5. PubMed ID: 2792431
[TBL] [Abstract][Full Text] [Related]
27. Lysophosphatidylcholine molecular species in low density lipoprotein and high density lipoprotein in alloxan-induced diabetic rats: effect of probucol.
Shi A; Yoshinari M; Iino K; Wakisaka M; Iwase M; Fujishima M
Exp Clin Endocrinol Diabetes; 1999; 107(6):337-42. PubMed ID: 10543409
[TBL] [Abstract][Full Text] [Related]
28. Discrepancies between the outcome of animal and human studies on the mode of action of probucol.
Beynen AC
Atherosclerosis; 1986 Sep; 61(3):249-51. PubMed ID: 3768092
[No Abstract] [Full Text] [Related]
29. [How do changes in the plasma concentration of HDL induced by probucol operate?].
Med Clin (Barc); 1988 Apr; 90(13):556-7. PubMed ID: 3393042
[No Abstract] [Full Text] [Related]
30. [Mechanism of action of hypolipemic drugs].
Fruchart JC
J Pharm Belg; 1992; 47(4):345-50. PubMed ID: 1403601
[TBL] [Abstract][Full Text] [Related]
31. Effect of probucol on hypercholesterolemia in renal transplant patients.
Okubo M; Nakamura M; Horii A; Kamata K; Takeuchi Y; Tsukamoto Y; Kobayashi N; Sato K; Endo T
Kidney Int Suppl; 1999 Jul; 71():S229-30. PubMed ID: 10412784
[TBL] [Abstract][Full Text] [Related]
32. Clinical and therapeutic use of probucol.
Berg A; Baumstark MW; Frey I; Halle M; Keul J
Eur J Clin Pharmacol; 1991; 40 Suppl 1():S81-4. PubMed ID: 2044650
[TBL] [Abstract][Full Text] [Related]
33. Treatment of the hyperlipidemia of the nephrotic syndrome: a controlled trial.
Valeri A; Gelfand J; Blum C; Appel GB
Am J Kidney Dis; 1986 Dec; 8(6):388-96. PubMed ID: 3544820
[TBL] [Abstract][Full Text] [Related]
34. Probucol, a new cholesterol lowering drug.
Nash DT
J Med; 1975; 6(5-6):305-15. PubMed ID: 768396
[TBL] [Abstract][Full Text] [Related]
35. Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis.
Glueck CJ
Ann Intern Med; 1982 Apr; 96(4):475-82. PubMed ID: 7039445
[TBL] [Abstract][Full Text] [Related]
36. [Cholesterol and bile acid dynamics: comparative aspects].
Lutton C
Reprod Nutr Dev; 1990; 30(2):145-60. PubMed ID: 2190572
[TBL] [Abstract][Full Text] [Related]
37. Probucol in long-term treatment of hypercholesterolemia.
Strandberg TE; Vanhanen H; Miettinen TA
Gen Pharmacol; 1988; 19(3):317-20. PubMed ID: 3046993
[TBL] [Abstract][Full Text] [Related]
38. Treatment of familial and non-familial hypercholesterolaemia: a review of HMG-CoA reductase inhibitors and probucol.
Tikkanen MJ; Helve E; Nikkilä EA
Eur Heart J; 1987 Aug; 8 Suppl E():97-101. PubMed ID: 3315684
[TBL] [Abstract][Full Text] [Related]
39. Effect of probucol on the composition of lipoproteins and on VLDL apoprotein B turnover.
Lock DR; Kuisk I; Gonen B; Patsch W; Schonfeld G
Atherosclerosis; 1983 Jun; 47(3):271-8. PubMed ID: 6882500
[TBL] [Abstract][Full Text] [Related]
40. The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemia.
Cortese C; Marenah CB; Miller NE; Lewis B
Atherosclerosis; 1982 Sep; 44(3):319-25. PubMed ID: 7150396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]